BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

Made-In-Singapore Cancer Drug ETC-159 Advances In Clinical Trials

A made-in-Singapore cancer drug, ETC-159, has advanced into the dose expansion portion of its Phase 1B clinical trial. The Phase 1B dose expansion st...

June 06, 2022 | News

Merck Advances Development Programs in Oncology Focusing on Novel Mechanisms and Pathways

New data from DNA Damage Response (DDR) inhibitor portfolio inform development path for this promising biology Clinical trials in locally advanced head ...

June 06, 2022 | News

4P-Pharma and Delta 4 Join Forces to Find and Develop Treatments for a Rare Autoimmune Chronic Liver Disease

Contributing to this collaboration, Delta 4 will apply its proprietary computational and iterative big data analytics platform to identify novel therapeuti...

June 03, 2022 | News

Standigm Signs MOU with Merck Korea for AI drug Discovery Research

Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, today announced the signing of a Memorandum of Unders...

June 02, 2022 | News

US FDA Clears IND for Cynata's Phase 2 Clinical Trial of CYP-001 in GvHD

Key Highlights: US FDA has cleared Cynata's IND application for a Phase 2 clinical trial of CYP-001 in patients with aGvHD – a major mil...

May 27, 2022 | News

Excelra Partners with HotSpot Therapeutics to Enhance Allosteric Drug Discovery Efforts

HotSpot Therapeutics plans to deploy data from Excelra's flagship product GOSTAR toward select protein targets to augment its allosteric inhibitor candidat...

May 26, 2022 | News

Eurofins Discovery Announces Formation of its New Scientific Advisory Board

The SAB is tasked with providing guidance on industry trends, growth opportunities and innovations that will further strengthen Eurofins Discovery's portfo...

May 25, 2022 | News

FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder

"As researchers and clinicians have gained knowledge about eosinophilic esophagitis in recent years, more cases of the disorder have been recognized and di...

May 23, 2022 | News

BD and Mitsubishi Gas Chemical Have Signed a Letter Of Intent (LOI) to Discuss a Partnership Agreement to Explore New Ways to Advance Biologic Drug Delivery

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. ...

May 18, 2022 | News

New therapeutic option to reduce risk of cardiovascular deaths and repeated hospitalizations among adult heart failure patients approved in Singapore

Over the course of the VICTORIA study, there was a 4.2% reduction in annualized absolute risk with VERQUVO™ (vericiguat) compared with pl...

May 18, 2022 | News

Fujitsu and RIKEN start joint research on next-generation IT drug discovery technology using the supercomputer Fugaku and simulation integrated AI

The joint research project will leverage high performance computing technologies and the supercomputer Fugaku to accelerate simulation integrated AI that c...

May 17, 2022 | News